Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
1
Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer
2010-09-01

Epigenetic changes in tumours are associated not only with cancer development and progression, but also with resistance to chemotherapy. Aberrant DNA methylation at CpG islands and associated epigenetic silencing are observed during the acquisition of drug resistance. However, it remains unclear whether all of the ...

PubMed Central

2
Histone Methylation and Epigenetic Silencing in Breast ...
2011-02-01

... Accession Number : ADA543626. Title : Histone Methylation and Epigenetic Silencing in Breast Cancer. Descriptive Note : Final rept. ...

DTIC Science & Technology

3
Histone Methylation and Epigenetic Silencing in Breast ...
2010-07-01

... Accession Number : ADA542206. Title : Histone Methylation and Epigenetic Silencing in Breast Cancer. Descriptive Note : Annual rept. ...

DTIC Science & Technology

4
Histone Methylation and Epigenetic Silencing in Breast ...
2008-07-01

... Accession Number : ADA491094. Title : Histone Methylation and Epigenetic Silencing in Breast Cancer. Descriptive Note : Annual rept. ...

DTIC Science & Technology

5
Epigenetic Silencing and Resistance to Imatinib Mesylate in ...
2007-07-01

... Accession Number : ADA474866. Title : Epigenetic Silencing and Resistance to Imatinib Mesylate in CML. Descriptive Note : Final rept. ...

DTIC Science & Technology

6
Epigenetic Silencing and Resistance to Imatinib Mesylate in ...
2006-07-01

... Accession Number : ADA469966. Title : Epigenetic Silencing and Resistance to Imatinib Mesylate in CML. Descriptive Note : Final rept. ...

DTIC Science & Technology

7
Epigenetic Silencing and Resistance to Imatinib Mesylate in ...
2005-07-01

... Accession Number : ADA447574. Title : Epigenetic Silencing and Resistance to Imatinib Mesylate in CML. Descriptive Note : Annual rept. ...

DTIC Science & Technology

8
Critical Role for Aberrant CpG Island Methylation in the Evolution and Progression of Breast Cancer: Characterization of Known Genes and Identification of Novel Genes.
2001-01-01

CpG island methylation is an epigenetic modification of DNA associated with the silencing of gene transcription. The hypothesis of this proposal is that breast cancers develop along different pathways, some involving aberrant CpG island methylation for ge...

National Technical Information Service (NTIS)

9
Critical Role for Aberrant CpG Island Methylation in the Evolution and Progression of Breast Cancer: Characterization of Known Genes and Identification of Novel Genes.
2000-01-01

CpG island methylation is an epigenetic modification of DNA associated with the silencing of gene transcription. The hypothesis of this proposal is that breast cancers develop along different pathways, some involving aberrant CpG island methylation for ge...

National Technical Information Service (NTIS)

10
Aberrant DNA methylation status of endometriosis: Epigenetics as the pathogenesis, biomarker and therapeutic target.
2011-06-09

Endometriosis, a common, benign, estrogen-dependent disease affecting 3-10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue that is found primarily in the peritoneum, ovaries and rectovaginal septum. Recently, endometriosis has been alternatively described as an immune disease, a genetic disease and a disease caused by exposure to environmental factors, ...

PubMed

11
Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.
2011-04-15

Epigenetic mechanisms maintain heritable changes in gene expression and chromatin organization over many cell generations. Importantly, deregulated epigenetic mechanisms play a key role in a wide range of human malignancies, including liver cancer. Hepatocellular carcinoma (HCC), which originates from the hepatocytes, is by far the most common liver ...

PubMed

12
Metabolic defects provide a spark for the epigenetic switch in cancer
2009-04-10

Cancer is a pathology that is associated with aberrant gene expression and an altered metabolism. While changes in gene expression have historically been attributed to mutations, it has become apparent that epigenetic processes also play a critical role in controlling gene expression during carcinogenesis. Global changes in epigenetic ...

PubMed Central

13
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
2010-09-03

Aberrant DNA methylation, in particular promoter hypermethylation and transcriptional silencing of tumor suppressor genes, has an important role in the development of many human cancers, including renal cell carcinoma (RCC). Indeed, apart from mutations in the well studied von Hippel-Lindau gene (VHL), the mutation frequency rates of known tumor suppressor ...

PubMed Central

14
Epigenetic silencing of RELN in gastric cancer.
2010-01-01

RELN (Reelin) is an extracellular glycoprotein that plays a critical role in neuronal migration. Here we show that the RELN gene is frequently silenced in gastric cancers (GCs) by aberrant promoter hypermethylation. Although RELN was strongly expressed in non-tumor gastric epithelia, its expression was weak, or absent, in GC cell lines and primary GC ...

PubMed

15
DNA methylation, genomic silencing, and links to nutrition and cancer.
2005-06-01

DNA methylation is a heritable epigenetic feature that is associated with transcriptional silencing, X-chromosome inactivation, genetic imprinting, and genomic stability. The addition of the methyl group is catalyzed by a family of DNA methyltransferases whose co-substrates are DNA and S-adenosylmethionine, the latter being derived from the methionine ...

PubMed

16
Whole Genome Epigenetics
2005-05-01

... changes, but to potentially create epigenetic changes by creating germline transgenic mice in which a target gene has been silenced by RNAi. ...

DTIC Science & Technology

17
Whole Genome Epigenetics
2004-06-01

... but to actually selectively create epigenetic changes by creating germline transgenic mice in which a target gene has been silenced by RNAi. ...

DTIC Science & Technology

18
Whole Genome Epigenetics
2003-05-01

... but to actually selectively create epigenetic changes by creating germline transgenic mice in which a target gene has been silenced by RNAi. ...

DTIC Science & Technology

19
Epigenetic Silencing and Resistance to Imatinib Mesylate in ...
2005-07-01

... 15. SUBJECT TERMS chronic myelogenous leukemia, epigenetics, DNA methylation, decitabine, imatinib, clinical trial 16. ...

DTIC Science & Technology

20
Novel oligoamine analogues inhibit lysine-specific demethylase 1 (LSD1) and induce re-expression of epigenetically silenced genes
2009-11-24

PurposeAbnormal DNA CpG island hypermethylation and transcriptionally repressive histone modifications are associated with the aberrant silencing of tumor suppressor genes. Lysine methylation is a dynamic, enzymatically-controlled process. Lysine-specific demethylase 1 (LSD1) has recently been identified as a histone lysine demethylase. LSD1 specifically ...

PubMed Central

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
21
The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma
2010-05-18

BackgroundKlotho was originally characterized as an anti-aging gene that predisposed Klotho-deficient mice to a premature aging-like syndrome. Recently, KLOTHO was reported to function as a secreted Wnt antagonist and as a tumor suppressor. Epigenetic gene silencing of secreted Wnt antagonists is considered a common event in a wide range of human ...

PubMed Central

22
DNA methylation and cancer pathways in gastrointestinal tumors.
2008-12-01

Cancer is fundamentally a genetic and epigenetic disease that requires the accumulation of genomic alterations that inactivate tumor suppressors and activate proto-oncogenes. In addition to genetic mutation or allelic loss, epigenetic gene silencing associated with DNA methylation is now recognized as an alternative mechanism by which ...

PubMed

23
Comparative Epigenomics of Human and Mouse Mammary Tumors
2009-01-01

Gene silencing by aberrant epigenetic chromatin alteration is a well-recognized event contributing to tumorigenesis. While genetically engineered tumor-prone mouse models have proven a powerful tool in understanding many aspects of carcinogenesis, to date few studies have focused on epigenetic alterations in mouse ...

PubMed Central

24
(Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.
2010-07-22

The recently discovered enzyme lysine-specific demethylase 1 (LSD1) plays an important role in the epigenetic control of gene expression, and aberrant gene silencing secondary to LSD1 overexpression is thought to contribute to the development of cancer. We recently reported a series of (bis)guanidines and (bis)biguanides that are ...

PubMed

25
(Bis)urea and (Bis)thiourea Inhibitors of Lysine-Specific Demethylase 1 as Epigenetic Modulators
2010-07-22

The recently discovered enzyme lysine-specific demethylase 1 (LSD1) plays an important role in the epigenetic control of gene expression, and aberrant gene silencing secondary to LSD1 over expression is thought to contribute to the development of cancer. We recently reported a series of (bis)guanidines and (bis)biguanides that are ...

PubMed Central

26
Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter
2011-06-10

BackgroundLong-term gene silencing throughout cell division is generally achieved by DNA methylation and other epigenetic processes. Aberrant DNA methylation is now widely recognized to be associated with cancer and other human diseases. Here we addressed the contribution of the multifunctional nuclear factor CTCF to the ...

PubMed Central

27
Piwis and piwi-interacting RNAs in the epigenetics of cancer.
2011-09-16

An increasing body of evidence suggests that cancer cells acquire "stem-like" epigenetic and signaling characteristics during the tumorigenic process, including global DNA hypo-methylation, gene-specific DNA hyper-methylation, and small RNA deregulation. RNAs have been known to be epigenetic regulators, both in stem cells and in differentiated cells. A ...

PubMed

28
Double-strand breaks and the concept of short- and long-term epigenetic memory.
2010-12-21

Double-strand breaks represent an extremely cytolethal form of DNA damage and thus pose a serious threat to the preservation of genetic and epigenetic information. Though it is well-known that double-strand breaks such as those generated by ionising radiation are among the principal causative factors behind mutations, chromosomal aberrations, genetic ...

PubMed

29
Histone modifications and chromatin organization in prostate cancer
2010-08-01

Epigenetic mechanisms, including histone modifications, nucleosomal remodeling and chromosomal looping, contribute to the onset and progression of prostate cancer. Recent technical advances significantly increase our understanding of the genome-wide epigenetic regulation of gene expression in prostate cancer. Aberrant genomic ...

PubMed Central

30
The ATM gene is a target for epigenetic silencing in locally advanced breast cancer.
2004-12-16

Several epidemiological studies on ataxia-telangiectasia families indicate that obligate ATM heterozygotes display an elevated risk for developing breast cancer. However, a molecular basis for a potential link between diminished ATM function and sporadic breast malignancy remains elusive. Here, we show that 78% (18 out of a panel of 23) of surgically removed breast tumors (stage II or greater) ...

PubMed

31
TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia
2009-05-28

Aberrant methylation of tumor suppressor genes can lead to their silencing in many cancers. TSC-22 is a gene silenced in several solid tumors, but its function and the mechanism(s) responsible for its silencing are largely unknown. Here we demonstrate that the TSC-22 promoter is methylated in primary mouse T or ...

PubMed Central

32
Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific
2009-08-01

Both genetic and epigenetic mechanisms contribute to meningioma development by altering gene expression and protein function. To determine the relative contribution of each mechanism to meningioma development, we used an integrative approach measuring copy number and DNA methylation changes genomewide. We found that genetic alterations affected 1.9%, 7.4%, and 13.3% of the 691 ...

PubMed Central

33
Epigenetic Silencing and Resistance to Imatinib Mesylate in ...
2004-07-01

... LEUKEMIA, *METHYLATION, CLINICAL MEDICINE, HYPOTHESES, PATIENTS, PATHOGENESIS, TYROSINE, SULFITES, CLINICAL TRIALS. ...

DTIC Science & Technology

34
Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.
2011-01-13

The role of epigenetics and significance of aberrant gene regulation in etiology of cancer is a well-established phenomenon. The hallmark of cancer epigenetics is aberrant DNA methylation consisting of global hypomethylation and regional hypermethylation of tumor suppressor genes (TSGs) by DNA methyltransferases ...

PubMed

35
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies
2010-06-11

Cutaneous melanoma is a very aggressive neoplasia of melanocytic origin with constantly growing incidence and mortality rates world-wide. Epigenetic modifications (i.e., alterations of genomic DNA methylation patterns, of post-translational modifications of histones, and of microRNA profiles) have been recently identified as playing an important role in melanoma development ...

PubMed Central

36
Microsoft PowerPoint - Verma.ppt

Epigenetics is the study of - mitotically heritable changes - not caused by DNA sequence alterations Epigenetic controls - essential for normal development - misdirected in cancer cells Background Misdirected epigenetic controls can cause - silencing of tumor suppressor genes - activation of oncogenes ...

Cancer.gov

37
Insulation of tumor suppressor genes by the nuclear factor CTCF.
2011-08-17

One of the most outstanding nuclear factors, which has chromatin insulator and transcriptional properties and also contribute to genomic organization, is the zinc-finger protein CCCTC-binding factor (CTCF). Among its multiple functions, a growing amount of evidence implicates CTCF in the epigenetic regulation of genes responsible for the control of the cell cycle, and its ...

PubMed

38
Coordinated Activation of Candidate Proto-Oncogenes and Cancer Testes Antigens via Promoter Demethylation in Head and Neck Cancer and Lung Cancer
2009-03-23

BackgroundEpigenetic alterations have been implicated in the pathogenesis of solid tumors, however, proto-oncogenes activated by promoter demethylation have been sporadically reported. We used an integrative method to analyze expression in primary head and neck squamous cell carcinoma (HNSCC) and pharmacologically demethylated cell lines to identify ...

PubMed Central

39
Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis.
2010-08-16

Antineutrophil cytoplasmic autoantibody (ANCA) causes vascular injury that leads to small-vessel vasculitis. Patients with ANCA aberrantly express neutrophil granule-encoding genes, including 2 that encode autoantigens: proteinase 3 (PR3) and myeloperoxidase (MPO). To uncover a potential transcriptional regulatory mechanism for PR3 and MPO disrupted in patients with ANCA ...

PubMed

40
Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis
2010-08-16

Antineutrophil cytoplasmic autoantibody (ANCA) causes vascular injury that leads to small-vessel vasculitis. Patients with ANCA aberrantly express neutrophil granule�encoding genes, including 2 that encode autoantigens: proteinase 3 (PR3) and myeloperoxidase (MPO). To uncover a potential transcriptional regulatory mechanism for PR3 and MPO disrupted in patients with ANCA ...

PubMed Central

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
41
Genes methylated by DNA methyltransferase 3b are similar in mouse intestine and human colon cancer
2011-04-01

Human cancer cells frequently have regions of their DNA hypermethylated, which results in transcriptional silencing of affected genes and promotion of tumor formation. However, it is still unknown whether cancer-associated aberrant DNA methylation is targeted to specific genomic regions, whether this methylation also occurs in noncancerous cells, and ...

PubMed Central

42
State-dependent changes in the expression of DNA methyltransferases in mood disorder patients.
2011-05-17

Aberrant transcriptional regulation may be one of the key components of the pathophysiology of mood disorders. DNA methylation generally acts as an epigenetic gene silencing mechanism and is catalyzed by a group of enzymes known as DNA methyltransferases (DNMTs). Several lines of evidence have suggested aberrant ...

PubMed

43
Identification of four potential epigenetic modulators from the NCI structural diversity library using a cell-based assay.
2010-12-22

Epigenetic pathways help control the expression of genes. In cancer and other diseases, aberrant silencing or overexpression of genes, such as those that control cell growth, can greatly contribute to pathogenesis. Access to these genes by the transcriptional machinery is largely mediated by chemical modifications of DNA or histones, ...

PubMed

44
Identification of Four Potential Epigenetic Modulators from the NCI Structural Diversity Library Using a Cell-Based Assay
2011-12-22

Epigenetic pathways help control the expression of genes. In cancer and other diseases, aberrant silencing or overexpression of genes, such as those that control cell growth, can greatly contribute to pathogenesis. Access to these genes by the transcriptional machinery is largely mediated by chemical modifications of DNA or histones, ...

PubMed Central

45
Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer.
2011-05-01

Aberrant Wnt/?-catenin signaling is a driving force during initiation and progression of colorectal cancer. Yet, the Wnt/?-catenin targets CDX1, EPHB2, EPHB3 and EPHB4 (EPHB2-4) act as tumor suppressors in intestinal epithelial cells and frequently appear to be transcriptionally silenced in carcinomas. The molecular mechanisms which underlie the apparent ...

PubMed

46
Reversal of Estrogen Receptor Beta Epigenetic Gene ...
2009-06-01

... Title : Reversal of Estrogen Receptor Beta Epigenetic Gene Silencing in Prostatic Adenocarcinoma by Soy Protein-Derived Isoflavonoid ...

DTIC Science & Technology

47
Histone Methylation and Epigenetic Silencing in Breast ...
2008-07-01

... EZH2 is a histone methyltransferase that modifies ... epigenetic modification states of histones are also implicated in oncogenesis [2,7,8]. Particular ...

DTIC Science & Technology

48
Locus dependence in epigenetic chromatin silencing.
2010-07-22

Current biological models of epigenetic switches built on chromatin modifications lead to strong constraints on the repertoire of dynamic behaviors for the system. We use the structure of the bifurcation diagram of the underlying dynamical system to explain the existing single cell data in silencing by the SIR system in yeast. PMID:20655355

PubMed

49
Epigenetic Silencing and Resistance to Imatinib Mesylate in CML.
2006-01-01

Resistance to Imatinib mesylate is emerging as a real clinical problem in the management of chronic myelogenous leukemia (CML). In this project we are exploring the hypothesis that epigenetic silencing associated with promoter DNA methylation mediates res...

National Technical Information Service (NTIS)

50
Epigenetic Silencing and Resistance to Imatinib Mesylate in CML.
2004-01-01

Resistance to Imatinib mesylate is emerging as a real clinical problem in the management of chronic myelogenous leukemia (CML). In this project, we are exploring the hypothesis that epigenetic silencing associated with promoter DNA methylation mediates re...

National Technical Information Service (NTIS)

51
WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.
2011-09-16

Aberrant activation of the Wnt/?-catenin signaling axis is a prominent oncogenic mechanism in numerous cancers including cervical cancer. Wnt inhibitory factor-1 (WIF1) is a secreted protein that binds Wnt and antagonizes Wnt activity. While the WIF1 gene is characterized as a target for epigenetic silencing in some tumor types, WIF1 ...

PubMed

52
Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA Hypermethylation
2006-03-31

The class III histone deactylase (HDAC), SIRT1, has cancer relevance because it regulates lifespan in multiple organisms, down-regulates p53 function through deacetylation, and is linked to polycomb gene silencing in Drosophila. However, it has not been reported to mediate heterochromatin formation or heritable silencing for endogenous mammalian genes. ...

PubMed Central

53
Genetic and Epigenetic Silencing of the AS3 Proliferative rrest ...
2005-04-01

... ENGINEERING, ABLATION, HORMONES, SAMPLING, GENETIC MAPPING, ANDROGENS, EMBRYOLOGY, METHYLATION, HISTOLOGY, HOT ...

DTIC Science & Technology

54
Genetic and Epigenetic Silencing of the AS3 Proliferative ...
2004-04-01

... CHEMICAL AGENTS, GENES, MARKERS, SUBSTITUTES, NOISE REDUCTION, DEATH, GENETIC MAPPING, METHYLATION, EMBRYOLOGY. ...

DTIC Science & Technology

55
Epigenetic Silencing and Resistance to Imatinib Mesylate in ...
2007-07-01

... 14. ABSTRACT We performed analyses of DNA methylation data reported in the final report with clinical outcome of CML patients. ...

DTIC Science & Technology

56
Methylation silencing of angiopoietin-like 4 in rat and human mammary carcinomas.
2011-05-12

Aberrant DNA methylation is deeply involved in the development and progression of human breast cancers, but its inducers and molecular mechanisms are still unclear. To reveal such inducers and clarify the molecular mechanisms, animal models are indispensable. Here, to identify genes silenced by promoter DNA methylation in rat mammary carcinomas, we took a ...

PubMed

57
Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer
2008-06-20

Breast Cancer Metastasis Suppressor 1 (BRMS1) suppresses metastasis of human breast cancer, ovarian cancer and melanoma in athymic mice. Studies have also shown that BRMS1 is significantly downregulated in some breast tumors, especially in metastatic disease. However, the mechanisms which regulate BRMS1 expression are currently unknown. Upon examination of the BRMS1 promoter region by methylation ...

PubMed Central

58
Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells.
2010-06-14

Sin3A/B is a master transcriptional scaffold and corepressor that plays an essential role in the regulation of gene transcription and maintenance of chromatin structure, and its inappropriate recruitment has been associated with aberrant gene silencing in cancer. Sin3A/B are highly related, large, multidomian proteins that interact with a wide variety of ...

PubMed

59
Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells
2010-06-14

Sin3A/B is a master transcriptional scaffold and corepressor that plays an essential role in the regulation of gene transcription and maintenance of chromatin structure, and its inappropriate recruitment has been associated with aberrant gene silencing in cancer. Sin3A/B are highly related, large, multidomian proteins that interact with a wide variety of ...

PubMed Central

60
Inheritance of epigenetic chromatin silencing Diana David-Rus a,�,1

Inheritance of epigenetic chromatin silencing Diana David-Rus a,�,1 , Swagatam Mukhopadhyay a,b,1 Epigenetics Cell cycle Histone modification a b s t r a c t Maintenance of alternative chromatin states. In this paper, we study the systems biology of epigenetic inheritance by defining and analyzing general classes

E-print Network

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
61
DNA Methylation Profiles and Their Relationship with Cytogenetic Status in Adult Acute Myeloid Leukemia
2010-08-16

BackgroundAberrant promoter DNA methylation has been shown to play a role in acute myeloid leukemia (AML) pathophysiology. However, further studies to discuss the prognostic value and the relationship of the epigenetic signatures with defined genomic rearrangements in acute myeloid leukemia are required.Methodology/Principal FindingsWe carried out ...

PubMed Central

62
DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
2009-01-20

Promoter CpG methylation of tumour suppressor genes (TSGs) is an epigenetic biomarker for TSG identification and molecular diagnosis. We screened genome wide for novel methylated genes through methylation subtraction of a genetic demethylation model of colon cancer (double knockout of DNMT1 and DNMT3B in HCT116) and identified DLEC1 (Deleted in lung and oesophageal cancer 1), ...

PubMed Central

63
DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas
2010-08-30

Aberrant DNA methylation commonly occurs in cancer cells where it has been implicated in the epigenetic silencing of tumor suppressor genes. Additional roles for DNA methylation, such as transcriptional activation, have been predicted but have yet to be clearly demonstrated. The BCL6 oncogene is implicated in the pathogenesis of ...

PubMed Central

64
Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
2010-02-01

Aberrant methylation of promoter CpG islands is associated with transcriptional inactivation of tumor-suppressor genes in cancer. TFPI2, a Kunitz-type serine proteinase inhibitor, has been identified as a putative tumor-suppressor gene from genome-wide screening for aberrant methylation, using a microarray combined with the methyltransferase inhibitor ...

PubMed

65
Minireview: Epigenetic Changes in Ovarian Cancer
2009-09-02

Epigenetic aberrations, including DNA methylation, histone modifications, and micro-RNA dysregulation, are now well established in the development and progression of ovarian cancer, and their gradual accumulation is associated with advancing disease stage and grade. Epigenetic aberrations are relatively stable, ...

PubMed Central

66
A "mille-feuille" of silencing: Epigenetic control of transposable elements.
2011-04-12

Despite their abundance in the genome, transposable elements (TEs) and their derivatives are major targets of epigenetic silencing mechanisms, which restrain TE mobility at different stages of the life cycle. DNA methylation, post-translational modification of histone tails and small RNA-based pathways contribute to maintain TE ...

PubMed

67
Epigenetic-Mediated Dysfunction of the Bone Morphogenetic Protein Developmental Pathway Inhibits Differentiation of Human Glioblastoma Tumor Initiating Cells
2008-01-01

SUMMARYDespite similarities between tumor initiating cells with stem-like properties (TICs) and normal neural stem cells, we hypothesized that there may be differences in their differentiation potentials. We now demonstrate that both bone morphogenetic protein (BMP)-mediated and ciliary neurotrophic factor (CNTF)-mediated Jak/STAT-dependent astroglial differentiation is impaired due to ...

PubMed Central

68
Epigenetic Silencing of Erythropoietin in Human Cancers
2011-01-01

The glycoprotein hormone erythropoietin (EPO) is a key regulator in the production of red blood cells. EPO is produced mainly in the embryonic liver and kidney of adults. Other organs are also known to express varying amounts of EPO. In our study, we have analyzed the epigenetic regulation of EPO in human cancer cell lines by DNA methylation assays, chromatin ...

PubMed Central

69
WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
2010-10-01

Epigenetic DNA methylations plays an important role in oral carcinogenesis. The soluble frizzled receptor protein (SFRP) family together with WIF-1 and DKK-3 encodes antagonists of the WNT pathway. Silencing of these genes leads to constitutive WNT signalling. Because aberrant expression of beta-catenin might be associated with the ...

PubMed

70
Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growth
2011-05-24

BackgroundHomeobox genes murine Rhox5 and human RHOXF1 are expressed in early embryonic stages and then mostly restricted to germline tissues in normal adult, yet they are aberrantly expressed in cancer cells in vitro and in vivo . Here we study the epigenetic regulation and potential functions of Rhox5 gene.FindingsIn Rhox5 -silenced ...

PubMed Central

71
Role of TMS1 Silencing in the Resistance of Breast Cancer Cells to Apoptosis.
2004-01-01

Aberrant DNA methylation of promoter region CpG islands is associated with gene silencing and serves as an alternative to mutations in the inactivation of tumor suppressor genes in human cancers. Our lab has identified novel gene, TMS1, that is aberrantly...

National Technical Information Service (NTIS)

72
Frequent Long-Range Epigenetic Silencing of Protocadherin Gene Clusters on Chromosome 5q31 in Wilms' Tumor
2009-11-26

Wilms' tumour (WT) is a pediatric tumor of the kidney that arises via failure of the fetal developmental program. The absence of identifiable mutations in the majority of WTs suggests the frequent involvement of epigenetic aberrations in WT. We therefore conducted a genome-wide analysis of promoter hypermethylation in WTs and identified hypermethylation at ...

PubMed Central

73
Genetics and epigenetics of 1q rearrangements in hematological malignancies.
2007-01-01

Recently, we and others have described a novel class of chromosome aberrations that involves constitutive heterochromatin on human chromosome 1 (cytogenetic band 1q12). These anomalies are particularly frequent in B cell non-Hodgkins lymphoma (NHL) and multiple myeloma (MM) and, remarkably, almost invariably involve partial or total gain of chromosome 1q (including 1q12 ...

PubMed

74
Mechanisms of epigenetic silencing of the Rassf1a gene during estrogen-induced breast carcinogenesis in ACI rats
2010-03-14

Breast cancer, the most common malignancy in women, emerges through a multistep process, encompassing the progressive sequential evolution of morphologically distinct stages from a normal cell to hyperplasia (with and without atypia), carcinoma in situ, invasive carcinoma and metastasis. The success of treatment of breast cancer could be greatly improved by the detection at early stages of cancer. ...

PubMed Central

75
Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
2008-01-01

To identify epigenetically silenced cancer-related genes and to determine molecular effects of 5-aza-2'-deoxycytidine (Aza-dC) and/or trichostatin A (TSA) in multiple myeloma (MM), we analyzed global changes in gene expression profiles of three MM cell lines by microarray analysis. We identified up-regulation of several genes whose ...

PubMed

76
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal dock4 as a candidate pathogenic gene on chromosome 7q.
2011-04-30

Myelodysplastic syndromes (MDS) are characterized by abnormal and dysplastic maturation of all blood lineages. Even though epigenetic alterations have been seen in MDS marrow progenitors, very little is known about the molecular alterations in dysplastic peripheral blood cells. We analyzed the methylome of MDS leukocytes by the HELP assay and determined that it was globally ...

PubMed

77
Variegated silencing through epigenetic modifications of a large Xq region in a case of balanced X;2 translocation with Incontinentia Pigmenti-like phenotype.
2011-10-01

Molecular mechanisms underlying aberrant phenotypes in balanced X;autosome translocations are scarcely understood. We report the case of a de novo reciprocal balanced translocation X;2(q23;q33) presenting phenotypic alterations highly suggestive of Incontinentia Pigmenti (IP) syndrome, a genodermatosis with abnormal skin pigmentation and neurological failure, segregating as ...

PubMed

78
Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications
2011-06-27

Recent studies have shown aberrant expression of SOX11 in various types of aggressive B-cell neoplasms. To elucidate the molecular mechanisms leading to such deregulation, we performed a comprehensive SOX11 gene expression and epigenetic study in stem cells, normal hematopoietic cells and different lymphoid neoplasms. We observed that SOX11 expression is ...

PubMed Central

79
Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers.
2011-07-27

The DOK1 gene is a putative tumour suppressor gene located on the human chromosome 2p13 which is frequently rearranged in leukemia and other human tumours. We previously reported that the DOK1 gene can be mutated and its expression down-regulated in human malignancies. However, the mechanism underlying DOK1 silencing remains largely unknown. We show here that unscheduled ...

PubMed

80
Heterochromatin silencing of p53 target genes by a small viral protein.
2010-08-26

The transcription factor p53 (also known as TP53) guards against tumour and virus replication and is inactivated in almost all cancers. p53-activated transcription of target genes is thought to be synonymous with the stabilization of p53 in response to oncogenes and DNA damage. During adenovirus replication, the degradation of p53 by E1B-55k is considered essential for p53 inactivation, and is the ...

PubMed

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
81
Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications.
2011-06-27

Recent studies have shown aberrant expression of SOX11 in various types of aggressive B-cell neoplasms. To elucidate the molecular mechanisms leading to such deregulation, we performed a comprehensive SOX11 gene expression and epigenetic study in stem cells, normal hematopoietic cells and different lymphoid neoplasms. We observed that SOX11 expression is ...

PubMed

82
Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas.
2007-06-20

Aim: The aim of the present study was to examine DNA methylation and histone modification changes in hepatocellular carcinomas (HCC). Methods: DNA methylation in the P16, RASSF1a, progesterone receptor (PGR) and estrogen receptor alpha (ERalpha) promoters was determined by quantitative bisulfite-pyrosequencing technique in HCC patients. Histone H3-lysine (K) 4, H3-K9 and H3-K27 modifications in ...

PubMed

83
Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice.
2010-12-24

Overexposure of the human skin to solar ultraviolet (UV) radiation is the major etiologic factor for development of skin cancers. Here, we report the results of epigenetic modifications in UV-exposed skin and skin tumors in a systematic manner. The skin and tumor samples were collected after chronic exposure of the skin of SKH-1 hairless mice to UVB radiation using a ...

PubMed

84
Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists
2010-07-12

BackgroundDNA methylation and histone acetylation are epigenetic modifications that act as regulators of gene expression. Aberrant epigenetic gene silencing in tumours is a frequent event, yet the factors which dictate which genes are targeted for inactivation are unknown. DNA methylation and histone acetylation ...

PubMed Central

85
Epigenetics and psoriasis.
2011-09-19

Increasing evidence indicates that epigenetic mechanisms are involved in the pathogenesis of autoimmune rheumatic diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The pathogenesis of the organ-specific autoimmune disease psoriasis, however, remains poorly understood. Recent studies have shown that aberrant ...

PubMed

86
A metastable DWARF1 epigenetic mutant affecting plant stature in rice
2009-07-07

Epigenetic mutations confer heritable changes in gene expression that are not due to changes in the underlying sequence of the DNA. We identified a spontaneous rice mutant, Epi-d1, that shows a metastable dwarf phenotype. The phenotype is mitotically and meiotically inheritable and corresponds to the metastable epigenetic silencing of ...

PubMed Central

87
Epigenetic inheritance in Arabidopsis: selective silence Daniel Zilberman and Steven Henikoff

with DNA methylation and gene silencing, suggesting a possible epigenetic mechanism to explain the behaviorRNA-mediated silencing In addition to drm2, mutations in several other genes eliminate non-CG DNA methylation and prevent estab- lishment of any DNA methylation at FWA [9 ]. These genes encode components of a si

E-print Network

88
332 nature genetics � volume 29 � november 2001 Epigenetic silencing of CD4 in T cells committed to the

culminates in the maturation of helper (CD4+) and cytotoxic (CD8+) T cells from their common precursors when the silencer element was excised. The epigenetic inheritance of the silenced CD4 locus). Transcriptional upreg- ulation of both CD4 and CD8 in double-posi- tive cells is accompanied by rearrangement

E-print Network

89
Prediction of epigenetically regulated genes in breast cancer cell lines
2010-05-04

Methylation of CpG islands within the DNA promoter regions is one mechanism that leads to aberrant gene expression in cancer. In particular, the abnormal methylation of CpG islands may silence associated genes. Therefore, using high-throughput microarrays to measure CpG island methylation will lead to better understanding of tumor pathobiology and ...

Energy Citations Database

90
Xenoestrogen-Induced Epigenetic Repression of microRNA-9-3 in Breast Epithelial Cells
2009-06-23

Early exposure to xenoestrogens may predispose to breast cancer risk later in adult life. It is likely that long-lived, self-regenerating epithelial progenitor cells are more susceptible to these exposure injuries over time and transmit the injured memory through epigenetic mechanisms to their differentiated progeny. Here, we used progenitor-containing mammospheres as an in ...

PubMed Central

91
Radiation-stimulated epigenetic reprogramming of adaptive-response genes in the lung: an evolutionary gift for mounting adaptive protection against lung cancer.
2009-06-11

Humans are continuously exposed to low-level ionizing radiation from natural sources. However, harsher radiation environments persisted during our planet's early years and mammals survived via an evolutionary gift--a system of radiation-induced natural protective measures (adaptive protection). This system includes antioxidants, DNA repair, apoptosis of severely damaged cells, ...

PubMed

92
Radiation-Stimulated Epigenetic Reprogramming of Adaptive-Response Genes in the Lung: An Evolutionary Gift for Mounting Adaptive Protection Against Lung Cancer
2009-06-11

Humans are continuously exposed to low-level ionizing radiation from natural sources. However, harsher radiation environments persisted during our planet�s early years and mammals survived via an evolutionary gift - a system of radiation-induced natural protective measures (adaptive protection). This system includes antioxidants, DNA repair, apoptosis of severely damaged cells, ...

PubMed Central

93
Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
2011-01-31

The involvement of epigenetic aberrations in the development and progression of tumors is now well established. However, most studies have focused on the epigenetic inactivation of tumor suppressor genes during tumorigenesis and little is known about the epigenetic activation of cancer-associated genes, except for ...

PubMed Central

94
DNA methylation in endometrial cancer.
2010-08-16

Endometrial cancer is the most commonly diagnosed gynecological cancer, and it has been shown to be a complex disease driven by abnormal genetic, and epigenetic alterations, as well as environmental factors. Epigenetic changes resulting in aberrant gene expression are dynamic and modifiable features of many cancer types. A significant ...

PubMed

95
DNA Methylation in Endometrial Cancer
2010-08-16

Endometrial cancer is the most commonly diagnosed gynecological cancer, and it has been shown to be a complex disease driven by abnormal genetic, and epigenetic alterations, as well as environmental factors. Epigenetic changes resulting in aberrant gene expression are dynamic and modifiable features of many cancer types. A significant ...

PubMed Central

96
An N-ethyl-N-nitrosourea mutagenesis screen for epigenetic mutations in the mouse.
2003-08-01

The mammalian epigenetic phenomena of X inactivation and genomic imprinting are incompletely understood. X inactivation equalizes X-linked expression between males and females by silencing genes on one X chromosome during female embryogenesis. Genomic imprinting functionally distinguishes the parental genomes, resulting in parent-specific monoallelic ...

PubMed Central

97
Aberrant Promoter Methylation of Sparc in Ovarian Cancer1,2
2009-02-01

Epigenetic silencing of tumor suppressor genes is a new focus of investigation in the generation and proliferation of carcinomas. Secreted protein acidic and rich in cysteine (SPARC) is reportedly detrimental to the growth of ovarian cancer cells and has been shown to be epigenetically silenced in several cancers. ...

PubMed Central

98
Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer
2010-03-23

Nicotinic acetylcholine receptor (nAChR) genes form a highly conserved gene cluster at the lung cancer susceptibility locus 15q25.1. In this study, we show that the CHRN ? 3 gene encoding nAChR ? 3 subunit is a frequent target of aberrant DNA hypermethylation and silencing in lung cancer, whereas the adjacent CHRN ? 4 and CHRN ? 5 genes exhibit moderate ...

PubMed Central

99
Arabidopsis HDA6 Regulates Locus-Directed Heterochromatin Silencing in Cooperation with MET1
2011-04-28

Heterochromatin silencing is pivotal for genome stability in eukaryotes. In Arabidopsis, a plant-specific mechanism called RNA�directed DNA methylation (RdDM) is involved in heterochromatin silencing. Histone deacetylase HDA6 has been identified as a component of such ...

PubMed Central

100
Clinical Significance of Epigenetic Inactivation of hMLH1 and BRCA1 in Tunisian Patients with Invasive Breast Carcinoma
2009-07-29

Aberrant hypermethylation of gene promoter regions is one of the mechanisms for inactivation of tumour suppressor genes in many human cancers including breast carcinoma. In the current study, we aimed to assess by MSP, the methylation pattern of two cancer-related genes involved in DNA repair: hMLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) and BRCA1 (breast ...

PubMed Central

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
101
Searching the Epigenome for Novel Breast Cancer Tumor Suppressor.
2003-01-01

The initial proposal focused on developing technologies to uncover epigenetic changes that contribute to tumor development. The authors' initial attempts towards developing genome-wide approaches to identifying new genes silenced by epigenetic mechanisms ...

National Technical Information Service (NTIS)

102
Histone Methylation and Epigenetic Silencing in Breast Cancer.
2010-01-01

This research is to investigate the role of a chromatin-modifying enzyme, called EZH2, in breast cancer epigenetics and to develop strategies to identify chemical inhibitors of this enzyme. EZH2 is a histone methyltransferase which modifies lysine-27 of h...

National Technical Information Service (NTIS)

103
NCI Hosts International Conference on Epigenetic Mechanisms in Human Disease

National and international experts will meet at the National Institutes of Health (NIH) on May 30-31, 2002, to present recent advances in epigenetics in human disease. Epigenetics, a new frontier in genetics, focuses on changes in the genome other than DNA mutations that can affect gene expression, such as gene silencing. ...

Cancer.gov

104
Epigenetic phenomena and the evolution of plant allopolyploids Bao Liua

Epigenetic phenomena and the evolution of plant allopolyploids Bao Liua and Jonathan F. Wendelb epigenetic changes, including alteration in cytosine methylation patterns, rapid silencing in ribosomal RNA-related and likely arise from chromatin remodeling and its effects on epigenetic codes during and subsequent

E-print Network

105
Identification and functional analysis of epigenetically silenced microRNAs in colorectal cancer cells.
2011-06-16

Abnormal microRNA (miRNA) expression has been linked to the development and progression of several human cancers, and such dysregulation can result from aberrant DNA methylation. While a small number of miRNAs is known to be regulated by DNA methylation, we postulated that such epigenetic regulation is more prevalent. By combining MBD-isolated Genome ...

PubMed

106
Identification and Functional Analysis of Epigenetically Silenced MicroRNAs in Colorectal Cancer Cells
2011-06-16

Abnormal microRNA (miRNA) expression has been linked to the development and progression of several human cancers, and such dysregulation can result from aberrant DNA methylation. While a small number of miRNAs is known to be regulated by DNA methylation, we postulated that such epigenetic regulation is more prevalent. By combining MBD-isolated Genome ...

PubMed Central

107
Methylation-sensitive Regulation of TMS1/ASC by the Ets Factor, GA-binding Protein-?*S?
2009-05-29

Epigenetic silencing involving the aberrant DNA methylation of promoter-associated CpG islands is one mechanism leading to the inactivation of tumor suppressor genes in human cancers. However, the molecular mechanisms underlying this event remains poorly understood. TMS1/ASC is a novel proapoptotic signaling factor that is subject ...

PubMed Central

108
Hypomethylation and Aberrant Expression of the Glioma Pathogenesis-Related 1 Gene in Wilms Tumors

Wilms tumors (WTs) have a complex etiology, displaying genetic and epigenetic changes, including loss of imprinting (LOI) and tumor suppressor gene silencing. To identify new regions of epigenetic perturbation in WTs, we screened kidney and tumor DNA using CpG island (CGI) ...

PubMed Central

109
DNA Methylation Directly Silences Genes with Non-CpG Island Promoters and Establishes a Nucleosome Occupied Promoter.
2011-08-11

Despite the fact that 45% of all human gene promoters do not contain CpG islands, the role of DNA methylation in control of non-CpG island promoters is controversial and its relevance in normal and pathological processes is poorly understood. Among the few studies which investigate the correlation between DNA methylation and expression of genes with non-CpG island promoters, the majority do not ...

PubMed

110
Chromatin inactivation precedes de novo dna methylation during the progressive epigenetic silencing of the rassf1a promoter
2005-02-23

Epigenetic inactivation of the RASSF1A tumor suppressor by CpG island methylation was frequently detected in cancer. However, the mechanisms of this aberrant DNA methylation are unknown. In the RASSF1A promoter, we characterized four Sp1 sites, which are frequently methylated in cancer. We examined the functional relationship between DNA methylation, ...

Energy Citations Database

111
The epigenetic origin of aneuploidy.
2008-03-01

Theodore Boveri, eminent German pathologist, observed aneuploidy in cancer cells more than a century ago and suggested that cancer cells derived from a single progenitor cell that acquires the potential for uncontrolled continuous proliferation. Currently, it is well known that aneuploidy is observed in virtually all cancers. Gain and loss of chromosomal material in neoplastic cells is considered ...

PubMed

112
The Epigenetic Origin of Aneuploidy
2008-03-01

Theodore Boveri, eminent German pathologist, observed aneuploidy in cancer cells more than a century ago and suggested that cancer cells derived from a single progenitor cell that acquires the potential for uncontrolled continuous proliferation. Currently, it is well known that aneuploidy is observed in virtually all cancers. Gain and loss of chromosomal material in neoplastic cells is considered ...

PubMed Central

113
DNA methylation changes in murine breast adenocarcinomas allow the identification of candidate genes for human breast carcinogenesis.
2011-03-04

Epigenetic inactivation due to aberrant promoter methylation is a key process in breast tumorigenesis. Murine models for human breast cancer have been established for nearly every important human oncogene or tumor suppressor gene. Mouse-to-human comparative gene expression and cytogenetic profiling have been widely investigated for these models; however, ...

PubMed

114
Genetic and Epigenetic Silencing of the AS3 Proliferative rrest ...
2005-04-01

... cell line. In the second year we analyzed DNA methylation in the entire CpG island of the APRIN promoter. We identified ...

DTIC Science & Technology

115
Therapeutic Insights From a Novel Breast Tumor Suppressor Pathway.
2005-01-01

Epigenetic gene silencing is a common element of breast cancers. The specific genes targeted and the mechanisms of silencing, and how these relate to disease progression and outcome, are not well understood. This research project has 1) identified a new b...

National Technical Information Service (NTIS)

116
Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer.
2011-07-22

microRNAs (miRNA) are non-coding RNAs that negatively control gene expression by cleaving or inhibiting the translation of target gene mRNAs. We used a microarray-based transcriptomic analysis to identify miRNA expression levels that changed in response to epigenetic factors. Specifically, we searched for increased expression of miRNAs prepared from colon cancer cell line ...

PubMed

117
MeInfoText: associated gene methylation and cancer information from text mining
2008-01-14

BackgroundDNA methylation is an important epigenetic modification of the genome. Abnormal DNA methylation may result in silencing of tumor suppressor genes and is common in a variety of human cancer cells. As more epigenetics research is published electronically, it is desirable to extract relevant information from biological ...

PubMed Central

118
Epigenetic Changes in DNA Methylation in Breast Cancer.
2001-01-01

It is now clear that aberrant DNA methylation observed in cancer cells is not restricted to a few CpG islands, but affects multiple loci. When this epigenetic event occurs at the 5-end of the regulatory region of genes, it is frequently associated with tr...

National Technical Information Service (NTIS)

119
Histone methylation is a critical regulator of the abnormal expression of POU5F1 and RASSF1A in testis cancer cell lines.
2011-04-01

DNA and histone methylation are epigenetic modifications functioning in transcriptional control and have been implicated in the deregulation of gene expression in cancer. As a first step to determine if histone methylation could be involved in testis cancer pathogenesis, we performed immunofluorescent localization of histone H3 methylation at lysine 4 (H3-K4; gene activating) ...

PubMed

120
Epigenetic reprogramming during vegetative phase change in maize
2010-12-21

An important step during plant development is the transition from juvenile to adult growth. It is only after this transition that plants are reproductively competent. Given the great danger that transposon activity represents to the germ line, this may also be an important period during development with respect to transposon regulation and silencing. We demonstrate that a ...

PubMed Central

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
121
Role of nuclear architecture in epigenetic alterations in cancer.
2011-03-29

It is widely accepted that cancer results from an array of epigenetic and genetic alterations, particularly aberrant epigenetic patterns that are a hallmark of every cancer type studied. Another well-known feature of cancer cells is the array of abnormalities in their nuclear structure. Although it is known that nuclear structure has ...

PubMed

122
Role of TMS1 Silencing in the Resistance of Breast Cancer Cells to Apoptosis.
2006-01-01

Aberrant DNA methylation of promoter region CpG islands is associated with gene silencing and serves as an alternative to mutations in the inactivation of tumor suppressor genes in human cancers. We identified a gene TMS1 (for Target of Methylation-mediat...

National Technical Information Service (NTIS)

123
Lung cancer

Epigenetic is the study of heritable changes in gene expression that occur without changes in DNA sequence. This process is important for gene expression and genome stability and its disruption is now thought to play a key role in the onset and progression of numerous tumor types. The most studied epigenetic phenomena includes post-translational ...

PubMed Central

124
Sustained IL-6/STAT-3 Signaling in Cholangiocarcinoma Cells due to SOCS-3 Epigenetic Silencing
2006-11-07

Background and aimsIL-6 mediated STAT-3 phosphorylation (activation) is aberrantly sustained in cholangiocarcinoma cells resulting in enhanced Mcl-1 expression and resistance to apoptosis. Because SOCS-3 controls the IL-6/STAT-3 signaling pathway by a classic feedback loop, the aims of this study were to examine SOCS-3 regulation in human cholangiocarcinoma.MethodsSOCS-3 ...

PubMed Central

125
Sequential Molecular and Cellular Events during Neoplastic Progression: A Mouse Syngeneic Ovarian Cancer Model1
2005-10-01

AbstractStudies performed to identify early events of ovarian cancer and to establish molecular markers to support early detection and development of chemopreventive regimens have been hindered by a lack of adequate cell models. Taking advantage of the spontaneous transformation of mouse ovarian surface epithelial (MOSE) cells in culture, we isolated and characterized distinct transitional stages ...

PubMed Central

126
SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies
2010-07-12

BackgroundThe transcription factor SOX11 plays an important role in embryonic development of the central nervous system (CNS) and is expressed in the adult immature neuron but is normally not expressed in any other adult tissue. It has recently been reported to be implicated in various malignant neoplasms, including several lymphoproliferative diseases, by its specific expression and in some cases ...

PubMed Central

127
NPM-ALK oncogenic tyrosine kinase controls T cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells
2009-11-03

Transformed cells in lymphomas usually maintain the phenotype of the postulated normal lymphocyte from which they arise. By contrast, Anaplastic Large Cell Lymphoma (ALCL) is a T cell lymphoma with aberrant phenotype because of the defective expression of the T-cell receptor (TCR) and other T-cell specific molecules for still undetermined mechanisms. The majority of ALCL ...

PubMed Central

128
MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
2011-03-14

Aberrant activation of c-kit proto-oncogene contributes to abnormal cell proliferation by altering the tyrosine kinase signaling and constitutes a crucial impetus for leukemogenesis. Epigenetic silencing of tumor-suppressive microRNAs (miRNAs) is a key oncogenic mechanism for the activation of oncogenes in tumors. In this study, ...

PubMed

129
IL-2R common ?-chain is epigenetically silenced by nucleophosphin�anaplastic lymphoma kinase (NPM-ALK) and acts as a tumor suppressor by targeting NPM-ALK
2011-07-19

Anaplastic lymphoma kinase (ALK), physiologically expressed only by certain neural cells, becomes highly oncogenic, when aberrantly expressed in nonneural tissues as a fusion protein with nucleophosphin (NPM) and other partners. The reason why NPM-ALK succeeds in transforming specifically CD4+ T lymphocytes remains unknown. The IL-2R common ?-chain ...

PubMed Central

130
Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival
2009-03-10

Aberrant expression of Eph and ephrin proteins has well-established functions in oncogenesis and tumour progression. We describe EphA1 expression in 6 colorectal cancer (CRC) cell lines, 18 controls and 125 CRC specimens. In addition, a well-characterised cohort of 53 paired normal colon and CRCs was also assessed. Expression of EphA1 mRNA was assessed by quantitative ...

PubMed Central

131
DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
2010-07-13

Background:The mitogen-activated protein kinase (MAPK) phosphatases or dual specificity phosphatases (DUSPs) are a family of proteins that catalyse the inactivation of MAPK in eukaryotic cells. Little is known of the expression, regulation or function of the DUSPs in human neoplasia.Methods:We used RT�PCR and quantitative PCR (qPCR) to examine the expression of DUSP16 mRNA. The methylation in ...

PubMed Central

132
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-?B�dependent DNA methyltransferase activity in acute myeloid leukemia
2008-02-15

Bortezomib reversibly inhibits 26S proteasomal degradation, interferes with NF-?B, and exhibits antitumor activity in human malignancies. Zinc finger protein Sp1 transactivates DNMT1 gene in mice and is functionally regulated through protein abundance, posttranslational modifications (ie, ubiquitination), or interaction with other transcription factors (ie, NF-?B). We hypothesize that inhibition ...

PubMed Central

133
Extended Abstracts for the 38th International Symposium of the Princess Takamatsu Cancer Research Fund

genetics and epigenetics in tumorigenesis; � modifier loci that influence these pathways of colon cancer of the four issues of this talk. #12;2 Somatic genetics and epigenetics in tumorigenesis In adenomagenesis processes: homologous somatic recombination1,2 ; intragenic mutation3 ; and apparent epigenetic ...

E-print Network

134
Epigenetic regulation of Wnt signaling pathway in urological cancer.
2010-05-10

Constitutive activation of the Wnt signaling pathway is a common feature of solid tumors and contributes to uncontrolled cell-growth and impaired differentiation. We hypothesized that gene silencing mediated through aberrant promoter methylation of upstream Wnt antagonist genes might result in beta-catenin accumulation, resulting in constitutive Wnt ...

PubMed

135
Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target.
2011-06-29

BACKGROUND Accumulating evidence suggests that various epigenetic aberrations play definite roles in the pathogenesis of endometriosis. We investigated the histone acetylation status in endometriosis and the application of the histone deacetylase inhibitors (HDACIs) for the treatment of endometriosis. METHODS The levels of acetylated histones in the ...

PubMed

136
Epigenetics, spermatogenesis and male infertility.
2011-04-16

Epigenetic modifications characterized by DNA methylation, histone modifications, and chromatin remodeling are important regulators in a number of biological processes, including spermatogenesis. Several genes in the testes are regulated through epigenetic mechanisms, indicating a direct influence of epigenetic mechanisms on the ...

PubMed

137
The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence.
2011-06-03

Gene expression-based prediction of genomic copy number aberrations in the chromosomal region 12q13 to 12q15 that is flanked by MDM2 and CDK4 identified Wnt inhibitory factor 1 (WIF1) as a candidate tumor suppressor gene in glioblastoma. WIF1 encodes a secreted Wnt antagonist and was strongly downregulated in most glioblastomas as compared with normal brain, implying ...

PubMed

138
Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
2011-08-25

The aberrant methylation of promoter CpG islands is known to be a major inactivation mechanism of tumor-related genes, which plays a crucial role in the progression of silencing in human cancers including hepatocellular carcinoma (HCC). Thus, we sought to examine the promoter methylation status of five important DNA damage response genes in fresh-frozen ...

PubMed

139
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication.
2008-06-19

Posttranslationally modified histones and DNA hypermethylation frequently interplay to deregulate gene expression in cancer. We report that acute myeloid leukemia (AML) with an aberrant histone methyltransferase, the mixed lineage leukemia partial tandem duplication (MLL-PTD), exhibits increased global DNA methylation versus AML with MLL-wildtype (MLL-WT; P = .02). Among the ...

PubMed

140
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication
2008-09-01

Posttranslationally modified histones and DNA hypermethylation frequently interplay to deregulate gene expression in cancer. We report that acute myeloid leukemia (AML) with an aberrant histone methyltransferase, the mixed lineage leukemia partial tandem duplication (MLL-PTD), exhibits increased global DNA methylation versus AML with MLL-wildtype (MLL-WT; P = .02). Among the ...

PubMed Central

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
141
Genetic and epigenetic alterations during renal carcinogenesis.
2010-12-13

Renal cell carcinoma (RCC) is not a single entity, but comprises a group of tumors including clear cell RCC, papillary RCC and chromophobe RCC, which arise from the epithelium of renal tubules. The majority of clear cell RCCs, the major histological subtype, have genetic or epigenetic inactivation of the von Hippel-Lindau (VHL) gene. Germline mutations in the MET and fumarate ...

PubMed

142
Genetic and epigenetic alterations during renal carcinogenesis
2010-12-13

Renal cell carcinoma (RCC) is not a single entity, but comprises a group of tumors including clear cell RCC, papillary RCC and chromophobe RCC, which arise from the epithelium of renal tubules. The majority of clear cell RCCs, the major histological subtype, have genetic or epigenetic inactivation of the von Hippel-Lindau (VHL) gene. Germline mutations in the MET and fumarate ...

PubMed Central

143
TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
2010-11-09

BackgroundEpigenetic silencing of tumor suppressor genes play important roles in NPC tumorgenesis. Tissue factor pathway inhibitor-2 (TFPI-2), is a protease inhibitor. Recently, TFPI-2 was suggested to be a tumor suppressor gene involved in tumorigenesis and metastasis in some cancers. In this study, we investigated whether TFPI-2 was inactivated ...

PubMed Central

144
Lack of genetic and epigenetic changes in meningiomas without NF2 loss.
2006-03-01

Approximately 60% of sporadic meningiomas are caused by inactivation of the NF2 tumour suppressor gene. The causative gene for the remaining meningiomas is unknown. Previous studies have shown that these tumours have no recurrent karyotypic abnormalities. They differ from their NF2-related counterparts in that they are more often of the meningothelial subtype and are located preferentially in the ...

PubMed

145
Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components.
2010-01-01

It is well established that aberrant gene regulation by epigenetic mechanisms can develop as a result of pathological processes such as cancer. Methylation of CpG islands is an important component of the epigenetic code and a number of genes become abnormally methylated during tumorigenesis. Some bioactive food components have been ...

PubMed

146
Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components
2010-01-01

It is well established that aberrant gene regulation by epigenetic mechanisms can develop as a result of pathological processes such as cancer. Methylation of CpG islands is an important component of the epigenetic code and a number of genes become abnormally methylated during tumorigenesis. Some bioactive food components have been ...

PubMed Central

147
The RNA Silencing Pathway: The Bits and Pieces That Matter
2005-07-29

Cellular pathways are generally proposed on the basis of available experimental knowledge. The proposed pathways, however, may be inadequate to describe the phenomena they are supposed to explain. For instance, by means of concise mathematical models we are able to reveal shortcomings in the current description of the pathway of RNA silencing. The ...

PubMed Central

148
NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
2011-07-28

Promoter hypermethylation-mediated silencing of tumor suppressor genes (TSGs) is a hallmark of oncogenesis. Oxidored-nitro domain-containing protein 1 (NOR1) is a candidate TSG that is downregulated in nasopharyngeal carcinoma (NPC). In the present study, we identified a functional NOR1 promoter that is regulated by heat shock factor 1 and nuclear respiratory factor 1. The ...

PubMed

149
HDAC inhibitors and cancer therapy.
2011-01-01

Maintenance of normal cell growth and differentiation is highly dependent on coordinated and tight transcriptional regulation of genes. In cancer, genes encoding growth regulators are abnormally expressed. Particularly, silencing of tumor suppressor genes under the control of chromatin modifications is a major underlying cause of unregulated cellular proliferation and ...

PubMed

150
Global Reactivation of Epigenetically Silenced Genes in Prostate Cancer
2010-08-10

Transcriptional silencing associated with aberrant promoter hypermethylation is a common mechanism of inactivation of tumor suppressor genes in cancer cells. To globally profile the genes silenced by hypermethylation in prostate cancer, we screened a whole genome expression microarray for genes reactivated in the LNCaP, DU-145, PC-3 ...

PubMed Central

151
Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation
2010-05-01

Lck is a Src family protein tyrosine kinase with predominant T cell expression. Aberrant expression or activation of Lck kinase has been reported in both lymphoid and nonlymphoid malignancies. We showed previously that the signal transduction pathway involving Janus kinase (JAK) and signal transducer and activator of transcription (STAT) is constitutively activated and ...

PubMed Central

152
A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors.
2011-01-10

The critical 8p22 tumor suppressor deleted in liver cancer 1 (DLC1) is frequently inactivated by aberrant CpG methylation and/or genetic deletion and implicated in tumorigeneses of multiple tumor types. Here, we report the identification and characterization of its new isoform, DLC1 isoform 4 (DLC1-i4). This novel isoform encodes an 1125-aa (amino acid) protein with distinct ...

PubMed

153
Bookmarking the genome: maintenance of epigenetic information.
2011-03-24

Mitotic inheritance of gene function is obligatory to sustain biological control. Emerging evidence suggests that epigenetic mechanisms are linked to transmission of cell fate, lineage commitment, and maintenance of cellular phenotype in progeny cells. Mechanisms of epigenetic memory include gene silencing by DNA methylation, ...

PubMed

154
An Elaborate Pathway Required for Ras-Mediated Epigenetic Silencing
2007-10-25

The conversion of a normal cell to a cancer cell is a stepwise process that typically involves the activation of oncogenes and inactivation of tumour suppressor and pro-apoptotic genes1. In many instances, inactivation of genes critical for cancer development occurs by epigenetic silencing that often involves hypermethylation of CpG-rich promoter ...

PubMed Central

155
Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis.
2006-01-01

A genome-wide screening study for identification of hypermethylated genes in invasive cervical cancer (ICC) was carried out to augment our previously discovered panel of three genes found to be useful for detection of ICC and its precursor neoplasia. Putatively hypermethylated and silenced genes were reactivated in four ICC cell lines by treatment with 5-aza-2'-deoxycytidine ...

PubMed

156
MicroRNAs in acute leukemia: from biological players to clinical contributors.
2011-06-24

MicroRNAs (miRNAs) are involved in the management of hematopoiesis. As a consequence, miRNA dysregulation causes disruption of the hematopoietic system and leukemia may arise. We here comprehensively discuss miRNAs found discriminative for cytogenetic and molecular subtypes of acute leukemia. These miRNAs are either known miRNAs involved in leukemogenesis with proven tumor suppressor or oncogenic ...

PubMed

157
Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population.
2011-07-01

The development and progression of colorectal cancer (CRC) is a multi-step process, and the Wnt pathways with its two molecular gladiators adenomatous polyposis coli (APC) and ?-catenin plays an important role in transforming a normal tissue into a malignant one. In this study, we aimed to investigate the role of aberrations in the APC and ?-catenin genes in the pathogenesis ...

PubMed

158
Stress-Induced Activation of Heterochromatic Transcription
2010-10-28

Constitutive heterochromatin comprising the centromeric and telomeric parts of chromosomes includes DNA marked by high levels of methylation associated with histones modified by repressive marks. These epigenetic modifications silence transcription and ensure stable inheritance of this inert state. Although environmental cues can alter ...

PubMed Central

159
Epigenetic reprogramming of breast cancer cells with oocyte extracts
2011-01-13

BackgroundBreast cancer is a disease characterised by both genetic and epigenetic alterations. Epigenetic silencing of tumour suppressor genes is an early event in breast carcinogenesis and reversion of gene silencing by epigenetic reprogramming can provide clues to the mechanisms responsible ...

PubMed Central

160
A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression
2011-01-05

BackgroundEpigenetic silencing can extend to whole chromosomal regions in cancer. There have been few genome-wide studies exploring its involvement in tumorigenesis.MethodsWe searched for chromosomal regions affected by epigenetic silencing in cancer by using Affymetrix microarrays and real-time quantitative ...

PubMed Central

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
161
Epigenetic alterations in aging
2010-08-06

Aging is a multifaceted process characterized by genetic and epigenetic changes in the genome. The genetic component of aging received initially all of the attention. Telomere attrition and accumulation of mutations due to a progressive deficiency in the repair of DNA damage with age remain leading causes of genomic instability. However, epigenetic ...

PubMed Central

162
Epigenetic chromatin silencing: bistability and front propagation
2007-11-07

The role of post-translational modification of histones in eukaryotic gene regulation is well recognized. Epigenetic silencing of genes via heritable chromatin modifications plays a major role in cell fate specification in higher organisms. We formulate a coarse-grained model of chromatin silencing in yeast and study the conditions ...

PubMed Central

163
Epigenetic chromatin silencing: bistability and front propagation
2007-12-01

The role of post-translational modification of histones in eukaryotic gene regulation is well recognized. Epigenetic silencing of genes via heritable chromatin modifications plays a major role in cell fate specification in higher organisms. We formulate a coarse-grained model of chromatin silencing in yeast and study the conditions ...

NASA Astrophysics Data System (ADS)

164
Epigenetic regulation of gene expression in physiological and pathological brain processes.
2011-04-01

Over the past decade, it has become increasingly obvious that epigenetic mechanisms are an integral part of a multitude of brain functions that range from the development of the nervous system over basic neuronal functions to higher order cognitive processes. At the same time, a substantial body of evidence has surfaced indicating that several neurodevelopmental, ...

PubMed

165
Epigenetic Changes in the Myelodysplastic Syndrome
2010-04-01

Epigenetic mechanisms such as DNA methylation and histone modifications drive stable, clonally propagated changes in genes expression and can therefore serve as molecular mediators of pathway dysfunction in neoplasia. MDS is characterized by frequent epigenetic abnormalities, including the hypermethylation of genes that control proliferation, adhesion, and ...

PubMed Central

166
Epigenetic regulation of repetitive elements is attenuated by prolonged heat stress in Arabidopsis.
2010-09-28

Epigenetic factors determine responses to internal and external stimuli in eukaryotic organisms. Whether and how environmental conditions feed back to the epigenetic landscape is more a matter of suggestion than of substantiation. Plants are suitable organisms with which to address this question due to their sessile lifestyle and diversification of ...

PubMed

167
Epigenetic Regulation of Repetitive Elements Is Attenuated by Prolonged Heat Stress in Arabidopsis[W][OA]
2010-09-28

Epigenetic factors determine responses to internal and external stimuli in eukaryotic organisms. Whether and how environmental conditions feed back to the epigenetic landscape is more a matter of suggestion than of substantiation. Plants are suitable organisms with which to address this question due to their sessile lifestyle and diversification of ...

PubMed Central

168
Paramutation: the tip of an epigenetic iceberg?
2009-11-27

Paramutation describes the transfer of an acquired epigenetic state to an unlinked homologous locus, resulting in a meiotically heritable alteration in gene expression. Early investigations of paramutation characterized a mode of change and inheritance distinct from mendelian genetics, catalyzing the concept of the epigenome. Numerous examples of paramutation and ...

PubMed Central

169
Epigenetic mechanisms in cognition.
2011-06-01

Although the critical role for epigenetic mechanisms in development and cell differentiation has long been appreciated, recent evidence reveals that these mechanisms are also employed in postmitotic neurons as a means of consolidating and stabilizing cognitive-behavioral memories. In this review, we discuss evidence for an "epigenetic code" in the central ...

PubMed

170
DNA Demethylating Antineoplastic Strategies
2010-03-01

Despite the involvement of genetic alterations in neoplastic cell transformation, it is increasingly evident that abnormal epigenetic patterns, such as those affecting DNA methylation and histone posttranslational modifications (PTMs), play an essential role in the early stages of tumor development. This finding, together with the evidence that epigenetic ...

PubMed Central

171
Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).
2009-11-01

Improvements in epigenetics have resulted in identification of a number of genes with aberrant hypermethylation associated with systematic occurrence of cancer. It is now evident that aberrant hypermethylation inactivates cancer-related genes including those associated with cell cycle control, apoptosis, and DNA repair. An ...

PubMed

172
SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
2009-05-08

The class III histone deacetylase SIRT1 (sir2) is important in epigenetic gene silencing. Inhibition of SIRT1 reactivates silenced genes, suggesting a possible therapeutic approach of targeted reversal of aberrantly silenced genes. In addition, SIRT1 may be involved in the well-known link ...

PubMed

173
SIRT1 Histone Deacetylase Expression Is Associated with Microsatellite Instability and CpG Island Methylator Phenotype in Colorectal Cancer
2009-05-08

The class III histone deacetylase SIRT1 plays an important role in epigenetic gene silencing. Inhibition of SIRT1 reactivates silenced genes, suggesting a possible therapeutic approach of targeted reversal of aberrantly silenced genes. In addition, SIRT1 may play a role in the well-known link ...

PubMed Central

174
Epigenetic silencing of transcription factor SIP1 in pancreatic cancer cells is associated with elevated expression and blood serum levels of microRNAs miR-200a,b
2010-06-15

Aberrant DNA methylation and miRNA expression play important roles in the pathogenesis of pancreatic cancer. While interrogating differentially methylated CpG islands in pancreatic cancer we identified two members of miR-200 family, miR-200a and miR-200b that were hypomethylated and overexpressed in pancreatic cancer. We also identified prevalent hypermethylation and ...

PubMed Central

175
The long noncoding RNA Kcnq1ot1 organises a lineage-specific nuclear domain for epigenetic gene silencing
2009-02-15

SummaryLong noncoding RNAs are implicated in a number of regulatory functions in eukaryotic genomes. The paternally expressed long noncoding RNA (ncRNA) Kcnq1ot1 regulates epigenetic gene silencing in an imprinted gene cluster in cis over a distance of 400 kb in the mouse embryo, whereas the silenced region extends over 780 kb in ...

PubMed Central

176
Environment-responsive transcription factors bind subtelomeric elements and regulate gene silencing
2011-01-04

Subtelomeric chromatin is subject to evolutionarily conserved complex epigenetic regulation and is implicated in numerous aspects of cellular function including formation of heterochromatin, regulation of stress response pathways and control of lifespan. Subtelomeric DNA is characterized by the presence of specific repeated segments that serve to propagate ...

PubMed Central

177
Transgenerational Inheritance and Resetting of Stress-Induced Loss of Epigenetic Gene Silencing in Arabidopsis
2010-05-21

Plants, as sessile organisms, need to sense and adapt to heterogeneous environments and have developed sophisticated responses by changing their cellular physiology, gene regulation, and genome stability. Recent work demonstrated heritable stress effects on the control of genome stability in plants�a phenomenon that was suggested to be of epigenetic nature. Here, we show ...

PubMed Central

178
Protein-coding genes are epigenetically regulated in Arabidopsis polyploids
2001-06-05

The fate of redundant genes resulting from genome duplication is poorly understood. Previous studies indicated that ribosomal RNA genes from one parental origin are epigenetically silenced during interspecific hybridization or polyploidization. Regulatory mechanisms for protein-coding genes in polyploid genomes are unknown, partly because of ...

PubMed Central

179
Genetic and Epigenetic Silencing of the AS3 Proliferative rrest Gene in Prostate Cancer.
2005-01-01

Prostate cancer is the second leading cause of death among American men. The present proposal extends the molecular progress in prostate cancer into clinical practice by developing innovative markers. The current androgen ablation treatment is initially t...

National Technical Information Service (NTIS)

180
Genetic and Epigenetic Silencing of the AS3 Proliferative Arrest Gene in Prostate Cancer.
2004-01-01

Prostate cancer is the second leading cause of death among American men. The present proposal extends the molecular progress in prostate cancer into clinical practice by developing innovative markers. The current androgen ablation treatment is initially t...

National Technical Information Service (NTIS)

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
181
Genetic and Epigenetic Silencing of the AS3 Proliferative ...
2004-04-01

Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8. Page 9. Page 10. Page 11. Page 12. Page 13. Page 14. Page 15. Page 16. Page ...

DTIC Science & Technology

182
Epigenetic silencing of transposable elements: A trade-off between reduced transposition and deleterious effects on neighboring gene expression
2009-08-01

Transposable elements (TEs) are ubiquitous genomic parasites. The deleterious consequences of the presence and activity of TEs have fueled debate about the evolutionary forces countering their expansion. Purifying selection is thought to purge TE insertions from the genome, and TE sequences are targeted by hosts for epigenetic silencing. However, the ...

PubMed Central

183
Epigenetic Silencing and Resistance to Imatinib Mesylate in CML.
2007-01-01

We performed analyses of DNA methylation data reported in the final report with clinical outcome of CML patients. DNA methylation significantly correlated with survival. CML patients with average methylation zscore values above zero had significantly shor...

National Technical Information Service (NTIS)

184
Epigenetic Silencing and Resistance to Imatinib Mesylate in ...
2006-07-01

... CP AP BC -1 0 1 2 Kruskal-Wallis test P value P<0.0001 Parameter Dunn's Multiple Comparison Test CP vs AP CP vs BC AP vs BC ...

DTIC Science & Technology

185
Epigenetic Silencing and Resistance to Imatinib Mesylate in ...
2004-07-01

Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8. Page 9. Page 10. Page 11. Page 12. Page 13. Page 14. Page 15. Page 16. Page ...

DTIC Science & Technology

186
Center for Cancer Research - Staff Pages

The 2.1-kb inverted repeat DNA sequences flank the mat2,3 silent region in two species of Schizosaccharomyces and are involved in epigenetic silencing in Schizosaccharomyces pombe. Genetics.

Cancer.gov

187
An epigenetic hypothesis of aging-related cognitive dysfunction.
2010-03-12

This brief review will focus on a new hypothesis for the role of epigenetic mechanisms in aging-related disruptions of synaptic plasticity and memory. Epigenetics refers to a set of potentially self-perpetuating, covalent modifications of DNA and post-translational modifications of nuclear proteins that produce lasting alterations in chromatin structure. ...

PubMed

188
An Epigenetic Hypothesis of Aging-Related Cognitive Dysfunction
2010-03-12

This brief review will focus on a new hypothesis for the role of epigenetic mechanisms in aging-related disruptions of synaptic plasticity and memory. Epigenetics refers to a set of potentially self-perpetuating, covalent modifications of DNA and post-translational modifications of nuclear proteins that produce lasting alterations in chromatin structure. ...

PubMed Central

189
Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
2006-06-26

Epigenetic editing of gene expression by aberrant methylation of DNA may help tumor cells escape attack from the innate and acquired immune systems. Resistance to antiproliferative effects and apoptosis induction by interferons (IFNs) was postulated to result from silencing of IFN response genes by promoter hypermethylation. Treatment ...

PubMed

190
Methylation Allelic Polymorphism (MAP) in Chorionic Gonadotropin ?5 (CGB5) and Its Association with Pregnancy Success
2011-01-20

Context: Increased epigenetic variability in the placenta may have evolved in response to its role in mediating the conflicting demands of the mother and fetus. One essential guardian of early pregnancy maintenance is the placental hormone human chorionic gonadotropin (HCG).Objective: Among the four primate-specific duplicate HCG?-coding genes, chorionic gonadotropin-?8 (CGB8) ...

PubMed Central

191
Integrative epigenomic and genomic analysis of malignant pheochromocytoma
2010-07-31

Epigenomic and genomic changes affect gene expression and contribute to tumor development. The histone modifications trimethylated histone H3 lysine 4 (H3K4me3) and lysine 27 (H3K27me3) are epigenetic regulators associated to active and silenced genes, respectively and alterations of these modifications have been observed in cancer. Furthermore, genomic ...

PubMed Central

192
High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications.
2009-08-01

During the last decade, high-throughput technologies including genomic, epigenomic, transcriptomic and proteomic have been applied to further our understanding of the molecular pathogenesis of this heterogeneous disease, and to develop strategies that aim to improve the management of patients with lung cancer. Ultimately, these approaches should lead to sensitive, specific and noninvasive methods ...

PubMed

193
Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.
2009-09-05

EphA5 is a member of the Eph receptor tyrosine kinase family, which plays a critical role in the regulation of carcinogenesis. Our previous DNA methylation microarray results suggested that the CpG islands in the EphA5 promoter exhibited higher methylation levels in breast cancer tissues. In this study, we further analyzed EphA5 gene expression profiles, methylation status, and clinical ...

PubMed

194
Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features.
2009-12-01

Promoter methylation is an important mechanism in gene silencing and is a key epigenetic event in cancer development. Homeobox A5 (HOXA5) is a master regulator of the morphogenesis and cell differentiation to be implicated as a tumor suppressor gene in breast cancer, but its role in lung cancer is still unknown. In this study, we have investigated the ...

PubMed

195
DNA methylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study.
2011-02-01

Aberrant DNA methylation is a major epigenetic mechanism of gene silencing in a wide range of human cancers. Previous studies on DNA methylation typically used paired tumor and normal-appearing surrounding tissues from cancer-bearing individuals. However, genomic DNA isolated from surrogate tissues such as blood cells represents an ...

PubMed

196
Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma.
2009-02-03

To identify novel methylation-silenced genes in gastric cancer, we carried out a genome-wide search for genes that are up-regulated after treatment with the demethylating agent, 5-aza-2'-deoxycytidine (5Aza-dC). When three gastric cancer cell lines (SNU-1,-601, and -719) were treated with 5Aza-dC, 143 genes were found to be upregulated by twofold or more using oligonucleotide ...

PubMed

197
Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer.
2005-07-10

ZAC is a paternally expressed, imprinted gene located on chromosome 6q24, within a region known to harbor a tumor suppressor gene for several types of neoplasia, including human ovarian cancer (HOC). We have failed to identify genetic mutations in the ZAC gene in tumor material. Many imprinted genes contain differentially allele-specific-methylated regions (DMR) and harbor promoter activity that ...

PubMed

198
Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
2011-01-01

Fragile X syndrome (FXS) is an X-linked condition associated with intellectual disability and behavioral problems. It is caused by expansion of a CGG repeat in the 5' untranslated region of the fragile X mental retardation 1 (FMR1) gene. This mutation is associated with hypermethylation at the FMR1 promoter and resultant transcriptional silencing. FMR1 ...

PubMed

199
DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer.
2011-08-22

MicroRNAs (miRNAs) are recognized as being central players in many biological processes and cellular pathways. Their roles in disease have been highlighted first by observation of their aberrant expression profiles in human tumors, and then by in vitro and in vivo functional studies in transformed cells and model organisms. One of the most commonly observed features of miRNAs ...

PubMed

200
DNA hypermethylation in lung cancer is targeted at differentiation-associated genes.
2011-08-01

Aberrant DNA hypermethylation of tumor suppressor genes is thought to be an early event in tumorigenesis. Many studies have reported the methylation status of individual genes with known involvement in cancer, but an unbiased assessment of the biological function of the collective of hypermethylated genes has not been conducted so far. Based on the observation that a variety ...

PubMed

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page